CREB1 and glioma: These results are consistent with studies linking cuproptosis to neurological disorders via pathways such as HSP70–TLR4–NLRP3-mediated inflammation [51], CREB–BDNF-dependent synaptic dysfunction [31], and glioma progression [52].